- Home
- YMAB vs RLTY Comparison
YMAB vs RLTY Comparison
Compare YMAB & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- RLTY
- Stock Information
- Founded
- YMAB 2015
- RLTY 2022
- Country
- YMAB United States
- RLTY United States
- Employees
- YMAB N/A
- RLTY N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- RLTY Investment Managers
- Sector
- YMAB Health Care
- RLTY Finance
- Exchange
- YMAB Nasdaq
- RLTY Nasdaq
- Market Cap
- YMAB 218.4M
- RLTY 259.2M
- IPO Year
- YMAB 2018
- RLTY N/A
- Fundamental
- Price
- YMAB $4.69
- RLTY $14.55
- Analyst Decision
- YMAB Buy
- RLTY
- Analyst Count
- YMAB 11
- RLTY 0
- Target Price
- YMAB $18.73
- RLTY N/A
- AVG Volume (30 Days)
- YMAB 318.1K
- RLTY 86.7K
- Earning Date
- YMAB 05-06-2025
- RLTY 01-01-0001
- Dividend Yield
- YMAB N/A
- RLTY 9.35%
- EPS Growth
- YMAB N/A
- RLTY N/A
- EPS
- YMAB N/A
- RLTY N/A
- Revenue
- YMAB $87,685,000.00
- RLTY N/A
- Revenue This Year
- YMAB N/A
- RLTY N/A
- Revenue Next Year
- YMAB $21.10
- RLTY N/A
- P/E Ratio
- YMAB N/A
- RLTY N/A
- Revenue Growth
- YMAB 3.38
- RLTY N/A
- 52 Week Low
- YMAB $3.86
- RLTY $11.38
- 52 Week High
- YMAB $17.78
- RLTY $14.60
- Technical
- Relative Strength Index (RSI)
- YMAB 47.75
- RLTY 48.03
- Support Level
- YMAB $4.46
- RLTY $12.90
- Resistance Level
- YMAB $5.44
- RLTY $14.05
- Average True Range (ATR)
- YMAB 0.45
- RLTY 0.50
- MACD
- YMAB 0.07
- RLTY 0.02
- Stochastic Oscillator
- YMAB 52.53
- RLTY 62.50
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.